Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Transcriptic Aims to Make the Biology Lab Programmable

    Aug 13, 2014, 12:15 PM by Michael Croft

    Bio-IT World | The Menlo Park startup Transcriptic is now hiring out its robotics lab to automate life science tasks — but its real innovation is a programming interface that lets users customize their lab procedures down to the smallest pipetting step.

    Full story
  • Modular Brain Model Joins Neurons in Three Dimensions

    Aug 12, 2014, 08:25 AM by Michael Croft
    New York Times | Scientists at Tufts University have produced a three-dimensional model of the brain in which rat neurons can be grown for months at a time in the lab.
    Full story
  • Bibby Scientific incorporates Qualoupe Lite into more instruments for better data tracking and storage

    Aug 12, 2014, 00:00 AM by Michael Croft
    STAFFORDSHIRE, UNITED KINGDOM - Aug 12, 2014 - Qualoupe Lite, Bibby Scientific’s low cost, intuitive laboratory information management system (LIMS), is now available across an even wider selection of the company’s laboratory equipment
    Full story
  • Pistoia Alliance Forms Expert Group on Controlled Substance Legislation

    Aug 11, 2014, 09:50 AM by Michael Croft
    Bio-IT World News Brief | The Pistoia Alliance, an industry group that addresses non-competitive problems shared by stakeholders in drug development, today announced the launch of an expert community to streamline how pharma companies and their partners track the laws governing the use and distribution of chemical substances worldwide.
    Full story
  • Pharma Investors Express Support for Biosimilars

    Aug 11, 2014, 08:50 AM by Michael Croft
    Pharmalot | A large investor group has been circulating a document asking pharmaceutical companies to pledge certain measures to foster the takeup of biosimilars in the U.S., including the acknowledgement of safety data from Europe.
    Full story
  • Certara’s New Muse Invent Allows Chemistry Researchers to Design Drug Candidates That Are Synthetically Feasible

    Aug 11, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Aug 11, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, announced today that its Muse molecular design workflow for the identification and optimization of lead drug candidates now has virtual synthetic chemistry capabilities
    Full story
  • Dotmatics announces New Academic Site License Program at the 248th ACS Meeting in San Francisco

    Aug 11, 2014, 00:00 AM by Michael Croft
    BISHOP'S STORTFORD, UK - Aug 11, 2014 - ~~Dotmatics is pleased to announce a new Academic Site License program that will provide ample access to the Dotmatics Platform for Universities and Schools around the world at a specially reduced subscription price
    Full story
  • DNAnexus, AllSeq Share HiSeq X Ten Data

    Aug 8, 2014, 14:25 PM by Michael Croft
    Bio-IT World News Brief | The Garvan Institute, one of the earliest users of the "$1000 genome" HiSeq X Ten platform, has provided two whole genome datasets for public analysis, through a partnership with DNAnexus and AllSeq.
    Full story
  • Data Virtualization Powers Next Generation Sample Intelligence

    Aug 8, 2014, 08:00 AM by Michael Croft
    Bio-IT World Contributed Commentary | With more than one billion samples stored in biobanks around the world, research advancements, genomics and biomarker development, and reduced research budgets are all driving the need for unified sample intelligence.
    Full story
  • The Genomics of Infectious Diseases

    Aug 7, 2014, 13:00 PM by Michael Croft
    Bio-IT World | The Genome Center for Infectious Diseases (GCID) at the University of Maryland in Baltimore is dedicated to bringing new genomics technologies to bear on the bacteria, fungi, and parasites that cause disease in humans and livestock. One of the first targets: artemesinin-resistant Plasmodium falciparum, the parasite that causes the most deadly type of malaria
    Full story
  • MolecularHealth Adds Renowned Oncologist to Advisory Board

    Aug 7, 2014, 00:00 AM by Michael Croft
    THE WOODLANDS, TX, UNITED STATES - Aug 7, 2014 - MolecularHealth announces the addition of Fadi Braiteh, M
    Full story
  • Tumor Cells Shedding their DNA Fingerprints

    Aug 5, 2014, 11:00 AM by Michael Croft
    Nature News | Circulating tumor DNA--released into the blood when a tumor cell dies--has the potential to tell us far more about the various mutations in cancers than just tissue biopsies.
    Full story
  • NIH Announces Last Round of Advanced DNA Sequencing Grants

    Aug 5, 2014, 08:55 AM by Michael Croft
    Bio-IT World News Brief | A new four-year program of grants to organizations developing DNA sequencing technologies, totaling $14.5 million, will bring to a close the Advanced DNA Sequencing Technology initiative that has been funded by the National Human Genome Research Institute for over a decade.
    Full story
  • 100,000 Genomes Project Expected to Meet Goal with New Funding

    Aug 4, 2014, 14:40 PM by Michael Croft
    Science Insider | U.K. Prime Minister David Cameron has announced that Genomics England, the publicly-owned company created one year ago with the mission of sequencing 100,000 human genomes, will receive the funding to reach its goal by the end of 2017.
    Full story
  • Certara Launches D360 in Japan to Improve Drug Discovery and Development Productivity

    Aug 4, 2014, 00:00 AM by Michael Croft
    TOKYO, JAPAN - Aug 4, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch in Japan of D360, its integrated solution for the query, analysis and visualization of drug discovery and development data
    Full story
  • What You Need to Know About the FDA's Push to Regulate Laboratory Developed Tests

    Aug 1, 2014, 13:15 PM by Michael Croft
    Bio-IT World | On Thursday afternoon, the FDA announced that it plans, for the first time, to regulate laboratory developed tests in the same way it does other diagnostics. Bio-IT World looks at the proposed regulations and what comes next.
    Full story
  • Craig Venter on the State of Genomics

    Aug 1, 2014, 09:00 AM by Michael Croft
    Technology Review | Craig Venter talked to MIT's Technology Review about genomics and  his new hire--the former head of Google Translate. When asked about how we're doing in genomics, Venter was terse.
    Full story
  • July News and Product Briefs

    Jul 31, 2014, 09:10 AM by Michael Croft
    Bio-IT World | News and product releases from around the industry, including new research initiatives in autism, lung cancer, malaria, and Phelan-McDermid Syndrome, and a new device for isolating circulating tumor cells.
    Full story
  • Pad Pipetter Eases Tedious Lab Work

    Jul 30, 2014, 12:00 PM by Michael Croft
    Bio-IT World News Brief | The Yaniv Erlich lab at MIT's Whitehead Institute, famous for its pioneering work in "genome hacking," has released an app to help lab technicians with complex pipetting procedures.
    Full story
  • Cambridge-Based Emulate Plans to Jumpstart Organ-on-a-Chip Market

    Jul 30, 2014, 08:20 AM by Michael Croft
    Bio-IT World | Emulate is not the first company to test the drug industry’s readiness for organs-on-chips, but after five years incubating at Harvard’s Wyss Institute, it’s entering the field with big industry partners, a plug-and-play product suite, and a toehold at the FDA.
    Full story
  • «
  • 391
  • 392
  • 393
  • 394
  • 395
  • 396
  • 397
  • 398 (current)
  • 399
  • 400
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy